Trials / Conditions / Stage IA Non-Small Cell Lung Carcinoma

Stage IA Non-Small Cell Lung Carcinoma

8 registered clinical trials studyying Stage IA Non-Small Cell Lung Carcinoma.

Status	Trial	Sponsor	Phase
Terminated	Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Ca NCT03366766	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
Completed	Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer NCT03091816	University of Southern California	—
Completed	S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) NCT02728596	SWOG Cancer Research Network	N/A
Completed	SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cel NCT02581787	Maximilian Diehn	Phase 1 / Phase 2
Terminated	Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Under NCT01886573	National Cancer Institute (NCI)	Phase 1
Terminated	Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer NCT01342770	National Cancer Institute (NCI)	Phase 2
Terminated	Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed NCT01207726	National Cancer Institute (NCI)	Phase 2
Completed	EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer NCT02154399	National Cancer Institute (NCI)	Phase 2